P2X7 receptor-dependent ATP-induced shedding of CD27 in mouse lymphocytes

Immunology Letters

Volumn 102, Issue 1, 2006, Pages 98-105

  Moon, Hana ^a   Na, Hye Young ^a   Chong, Kyung Hee ^a   Kim, Tae Jin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

ATP; CD27; P2X7 receptor; Shedding

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2,3 O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CD27 ANTIGEN; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; ILOMASTAT; IONOMYCIN; MATRIX METALLOPROTEINASE INHIBITOR; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; WORTMANNIN; PEPTIDE HYDROLASE; PURINE P2 RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL MEMORY; LYMPHOCYTE; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SPLEEN LYMPHOCYTE; SUPERNATANT; T LYMPHOCYTE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD27; B-LYMPHOCYTES; DOWN-REGULATION; ENZYME ACTIVATION; MICE; PEPTIDE HYDROLASES; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 27744473014     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.08.004     Document Type: Article

References (40)

1. R.A. van Lier, J. Borst, T.M. Vroom, H. Klein, P. Van Mourik, and W.P. Zeijlemaker Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen J Immunol 139 1987 1589 1596
2. R.D. Bigler, Y. Bushkin, and N. Chiorazzi S152 (CD27) A modulating disulfide-linked T cell activation antigen J Immunol 141 1988 21 28
3. R. Arens, K. Tesselaar, P.A. Baars, G.M. van Schijndel, J. Hendriks, and S.T. Pals Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion Immunity 15 2001 801 812
4. J. Hendriks, Y. Xiao, and J. Borst CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool J Exp Med 198 2003 1369 1380
5. J. Hendriks, L.A. Gravestein, K. Tesselaar, R.A. van Lier, T.N. Schumacher, and J. Borst CD27 is required for generation and long-term maintenance of T cell immunity Nat Immunol 1 2000 433 440
6. K. Agematsu, S. Hokibara, H. Nagumo, and A. Komiyama CD27: a memory B-cell marker Immunol Today 21 2000 204 206
7. K. Agematsu, H. Nagumo, F.C. Yang, T. Nakazawa, K. Fukushima, and S. Ito B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production Eur J Immunol 27 1997 2073 2079
8. U. Klein, K. Rajewsky, and R. Kuppers Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells J Exp Med 188 1998 1679 1689
9. Y. Xiao, J. Hendriks, P. Langerak, H. Jacobs, and J. Borst CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation J Immunol 172 2004 7432 7441
10. H. Nagumo, and K. Agematsu Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis Immunology 94 1998 388 394
11. O.R. Baricordi, L. Melchiorri, E. Adinolfi, S. Falzoni, P. Chiozzi, and G. Buell Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor J Biol Chem 274 1999 33206 33208
12. P. Bodin, and G. Burnstock Increased release of ATP from endothelial cells during acute inflammation Inflamm Res 47 1998 351 354
13. F. Di Virgilio, P. Chiozzi, D. Ferrari, S. Falzoni, J.M. Sanz, and A. Morelli Nucleotide receptors: an emerging family of regulatory molecules in blood cells Blood 97 2001 587 600
14. R.A. North Molecular physiology of P2X receptors Physiol Rev 82 2002 1013 1067
15. D.A. Lammas, C. Stober, C.J. Harvey, N. Kendrick, S. Panchalingam, and D.S. Kumararatne ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors Immunity 7 1997 433 444
16. A. MacKenzie, H.L. Wilson, E. Kiss-Toth, S.K. Dower, R.A. North, and A. Surprenant Rapid secretion of interleukin-1beta by microvesicle shedding Immunity 15 2001 825 835
17. C. Mutini, S. Falzoni, D. Ferrari, P. Chiozzi, A. Morelli, and O.R. Baricordi Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation J Immunol 163 1999 1958 1965
18. R. Sluyter, and J.S. Wiley Extracellular adenosine 5′-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors Int Immunol 14 2002 1415 1421
19. B. Gu, L.J. Bendall, and J.S. Wiley Adenosine triphosphate-induced shedding of CD23 and l-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases Blood 92 1998 946 951
20. M.C. Gil, M.H. Lee, J.I. Seo, Y.L. Choi, M.K. Kim, and K.C. Jung Characterization and epitope mapping of two monoclonal antibodies against human CD99 Exp Mol Med 34 2002 411 418
21. A. Colomar, V. Marty, C. Medina, C. Combe, P. Parnet, and T. Amedee Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors J Biol Chem 278 2003 30732 30740
22. B.D. Humphreys, J. Rice, S.B. Kertesy, and G.R. Dubyak Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor J Biol Chem 275 2000 26792 26798
23. V. Budagian, E. Bulanova, L. Brovko, Z. Orinska, R. Fayad, and R. Paus Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B J Biol Chem 278 2003 1549 1560
24. P.J. Gough, K.J. Garton, P.T. Wille, M. Rychlewski, P.J. Dempsey, and E.W. Raines A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16 J Immunol 172 2004 3678 3685
25. G. Preece, G. Murphy, and A. Ager Metalloproteinase-mediated regulation of l-selectin levels on leucocytes J Biol Chem 271 1996 11634 11640
26. P.E. Dekkers, T. ten Hove, F.N. Lauw, H.R. Koene, P. Lumley, and S.J. van Deventer The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans Infect Immun 68 2000 3036 3039
27. U. Sahin, G. Weskamp, K. Kelly, H.M. Zhou, S. Higashiyama, and J. Peschon Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands J Cell Biol 164 2004 769 779
28. J.I. Elliott, and C.F. Higgins Major histocompatibility complex class I shedding and programmed cell death stimulated through the proinflammatory P2X7 receptor: a candidate susceptibility gene for NOD diabetes Diabetes 53 2004 2012 2017
29. S. Xanthoulea, M. Pasparakis, S. Kousteni, C. Brakebusch, D. Wallach, and J. Bauer Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases J Exp Med 200 2004 367 376
30. S. Adriouch, C. Dox, V. Welge, M. Seman, F. Koch-Nolte, and F. Haag Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor J Immunol 169 2002 4108 4112
31. R.Q. Hintzen, R. de Jong, C.E. Hack, M. Chamuleau, E.F. de Vries, and I.J. ten Berge A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex J Immunol 147 1991 29 35
32. A. De Milito, S. Aleman, R. Marenzi, A. Sonnerborg, D. Fuchs, and M. Zazzi Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects Clin Exp Immunol 127 2002 486 494
33. M. Gattorno, I. Prigione, S. Vignola, F. Falcini, S. Chiesa, and F. Morandi Levels of soluble CD27 in sera and synovial fluid and its expression on memory T cells in patients with juvenile idiopathic arthritides Clin Exp Rheumatol 20 2002 863 866
34. M. Seman, S. Adriouch, F. Scheuplein, C. Krebs, D. Freese, and G. Glowacki NAD-induced T cell death ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor Immunity 19 2003 571 582
35. H. Kawamura, F. Aswad, M. Minagawa, K. Malone, F. Koch-Nolte, and W.H. Schott P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide J Immunol 174 2005 1971 1979
36. T. Kobata, S. Jacquot, S. Kozlowski, K. Agematsu, S.F. Schlossman, and C. Morimoto CD27-CD70 interactions regulate B-cell activation by T cells Proc Natl Acad Sci USA 92 1995 11249 11253
37. K. Tesselaar, R. Arens, G.M. van Schijndel, P.A. Baars, M.A. van der Valk, and J. Borst Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions Nat Immunol 4 2003 49 54
38. W.A. Loenen, E. De Vries, L.A. Gravestein, R.Q. Hintzen, R.A. Van Lier, and J. Borst The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis Eur J Immunol 22 1992 447 455
39. J. Font, L. Pallares, J. Martorell, E. Martinez, A. Gaya, and J. Vives Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus Clin Immunol Immunopathol 81 1996 239 243
40. M.H. van Oers, S.T. Pals, L.M. Evers, C.E. van der Schoot, G. Koopman, and J.M. Bonfrer Expression and release of CD27 in human B-cell malignancies Blood 82 1993 3430 3436